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Host cell transcription mediated by all three RNA polymerases is rapidly inhibited after infection of mammalian cells with poliovirus
(PV). Both genetic and biochemical studies have shown that the virus-encoded protease 3C cleaves the TATA-binding protein and other
transcription factors at glutamine–glycine sites and is directly responsible for host cell transcription shut-off. PV replicates in the cytoplasm
of infected cells. To shut-off host cell transcription, 3C or a precursor of 3C must enter the nucleus of infected cells. Although the 3C protease
itself lacks a nuclear localization signal (NLS), amino acid sequence examination of 3D identified a potential single basic type NLS,
KKKRD, spanning amino acids 125–129 within this polypeptide. Thus, a plausible scenario is that 3C enters the nucleus in the form of its
precursor, 3CD, which then generates 3C by auto-proteolysis ultimately leading to cleavage of transcription factors in the nucleus. Using
transient transfection of enhanced green fluorescent protein (EGFP) fusion polypeptides, we demonstrate here that both 3CD and 3D are
capable of entering the nucleus in PV-infected cells. However, both polypeptides remain in the cytoplasm in uninfected HeLa cells.
Mutagenesis of the NLS sequence in 3D prevents nuclear entry of 3D and 3CD in PV-infected cells. We also demonstrate that 3CD can be
detected in the nuclear fraction from PV-infected HeLa cells as early as 2 h postinfection. Significant amount of 3CD is found associated with
the nuclear fraction by 3–4 h of infection. Taken together, these results suggest that both the 3D NLS and PV infection are required for the
entry of 3CD into the nucleus and that this may constitute a means by which viral protease 3C is delivered into the nucleus leading to host
cell transcription shut-off.
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Introduction and Semler, 1990; Leong et al., 2003). The viral proteasesPoliovirus (PV) is the prototype agent of a large group of
medically important viruses (picornaviruses), which include
those inducing infectious hepatitis (hepatitis A), common
cold (rhinoviruses), encephalitis, and myocarditis (coxsack-
ieviruses). The single-stranded, plus polarity RNA genome
of PV is translated into one large polyprotein which is co-
translationally processed by virus-encoded proteases 2A,
3C, and 3CD to generate the mature viral structural and non-
structural proteins (Krausslich and Wimmer, 1988; Lawson0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 Both authors contributed equally.have been extensively studied and found to be very specific
in polyprotein cleavage; 3C and 3CD cleave the polyprotein
at gln–gly (Q–G) pair while the 2A cleaves only at tyr–gly
(Y–G) bond. The proteases do not cleave every potential
cleavage site within the polyprotein; other determinants
such as accessibility and the context of the cleavage site
are also important.
Host cell transcription mediated by all three RNA
polymerases is rapidly inhibited after infection of mam-
malian cells with PV (Dasgupta et al., 2003; Kaariainen
and Ranki, 1984). RNA polymerase I (pol I), the enzyme
responsible for ribosomal RNA (rRNA) synthesis, is
inhibited first after infection of HeLa cells with PV.
Cellular mRNA synthesis by RNA polymerase II (pol II)
is inhibited next, followed by shut-off of RNA polymerase
III (pol III) that catalyzes synthesis of tRNA and 5S rRNA.
Previous studies from our laboratory have identified four
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(TF) that are either cleaved or degraded in PV-infected
cells: the TATA-binding protein (TBP), the cyclic AMP-
responsive element binding protein (CREB), the Octamer-
binding factor (Oct-1), and the transcriptional activator p53
(Clark and Dasgupta, 1990; Clark et al., 1993; Weidman et
al., 2001; Yalamanchili et al., 1996, 1997a,b). Similarly,
the pol III factor, TFIIIC, which interacts with pol III
promoters, as well as the 110-kDa TBP-associated factor
(TAF 110), a subunit of the pol I factor SL-1 are also
cleaved in PV-infected cells (Clark et al., 1991; Rubinstein
and Dasgupta, 1989; Rubinstein et al., 1992; and data not
shown). Both genetic and biochemical studies have shown
that the virus-encoded protease 3C cleaves the transcrip-
tion factors at glutamine–glycine sites and is directly
responsible for host cell transcription shut-off (Dasgupta
et al., 2003). The 3C protease of foot-and-mouth disease
virus (FMDV), another member of the Picornavirus family,
has been reported to induce proteolytic cleavage of host
cell histone H3 (Falk et al., 1990). The significance of
histone H3 cleavage by FMDV 3C, however, is not
known.
PV replicates in the cytoplasm of infected cells. To shut-
off host cell transcription, one or more viral gene products
must enter the nucleus of the infected host cell. Because PV-
encoded 3C protease has been shown to be directly respon-
sible for transcription shut-off, it is likely that 3C must enter
the nucleus of infected cells as it is, or in the form of a
precursor to bring about transcription shut-off. Previous
studies have reported detection of PV proteins including
the protease precursor 3CD in the nuclei of infected cells
(Bienz et al., 1982; Fernandez, 1982). The viral protease-
polymerase precursor 3CD (Harris et al., 1992) is a protease
itself, which efficiently cleaves the capsid precursor P1 to
VP0, VP3, and VP1 (Parsley et al., 1999; Ypma-Wong et al.,
1988) and is also able to auto-catalyze the formation of 3C
and 3D polypeptides (Wimmer et al., 1993). These findings
suggested to us that 3CD could interact with transcription
factors in the nuclei of infected cells. A computer search did
not reveal the presence of a nuclear localization signal
(NLS) in 3C, although the relatively small size (f20
kDa) of 3C may allow diffusion of 3C into the nucleus at
sufficiently high concentrations of this protease. Amino acid
sequence examination of 3D, however, identified a potential
single basic type NLS, KKKRD (Dingwall and Laskey,
1991), between amino acids 125 and 129 within this
polypeptide. This sequence is well conserved among enter-
oviruses and is present within the finger sub-domain of PV
3D (Hansen et al., 1997). Previous studies have shown that
triple alanine substitutions within the KKKRD sequence in
the PV infectious cDNA clone were lethal (Diamond and
Kirkegaard, 1994). Thus, it is possible to envision a scenario
in which 3C enters the nucleus in the form of its precursor,
3CD, which then generates 3C by auto-proteolysis leading
to cleavage of transcription factors. Using enhanced green
fluorescent protein (EGFP) fusion polypeptides, we demon-strate here that both 3CD and 3D are capable of entering the
nucleus in PV-infected cells. However, both polypeptides
remain in the cytoplasm in uninfected HeLa cells. Triple
alanine substitution of the first three or last three amino
acids of the NLS sequence prevents nuclear entry of 3D/
3CD in PV-infected cells. Using nuclear and cytoplasmic
fractions isolated from PV-infected HeLa cells, we demon-
strate that 3CD can be detected in the nuclear fraction as
early as 2 h postinfection. These results suggest that (i) both
the NLS and PV infection are required for the entry of 3CD
into the nucleus, and (ii) this 3C-containing precursor may
play an important role in host cell transcription shut-off by
delivering 3C protease inside the nucleus.Results
Expression of EGFP-fusion polypeptides
To investigate nuclear entry of the viral protease 3C, we
prepared the following EGFP fusion constructs using the
pEGFP-N1 vector: p3C-EGFP, p3D-EGFP, p3CD-EGFP,
and pm3CD-EGFP (Fig. 1A). The m3CD-EGFP construct
contained a mutation at the Q–G site of the 3C–3D junction
to prevent auto-proteolysis of the 3CD polypeptide into
mature 3C and 3D. HeLa cells were transfected with these
plasmids and cell-free extracts were prepared from trans-
fected cells after 24 h and examined for synthesis of EGFP-
fusion proteins by immunoblotting using an antibody to
EGFP. As can be seen in Fig. 1B, EGFP was highly
expressed in cells transfected with the pEGFP (lane 2).
There was fairly good expression of 3C-EGFP (f45 kDa)
in cells transfected with p3C-EGFP; however, significant
amount of free EGFP was also detected in the immunoblot
(lane 3). This could be due to proteolysis of 3C-EGFP. Both
the f77-kDa 3D-EGFP (lane 4) and f97-kDa 3CD-EGFP
(lane 5) were also expressed and appeared to be stable under
the conditions used for expression. The expression of
m3CD-EGFP was comparable to that of 3CD-EGFP (lane
6). The Western analysis detected a band having an approx-
imate molecular weight of 55 kDa that migrated between
3D-EGFP and 3C-EGFP (indicated by an arrowhead).
Although the precise identity of the 55-kDa polypeptide is
not known, we assume it contains part of the 3D sequence
linked to EGFP.
PV infection results in nuclear entry of 3D and 3CD
The majority of the PV-encoded proteins are present in
the cytoplasm of infected cell. To examine whether PV
infection leads to nucleo-cytoplasmic relocalization of the
protease precursor 3CD, HeLa cells were first transfected
with the recombinant pEGFP-fusion plasmids and then
either mock-infected or infected with PV. Initially, a time
course of infection revealed nuclear entry of significant
amounts of 3CD-EGFP between 3 and 4 h of infection
Fig. 1. Expression of EGFP-fusion polypeptides. (A) Schematic representation of the constructs used for expression of p3CD-EGFP, p3D-EGFP, and p3C-
EGFP. The shaded area within the 3D sequence shows the location of the NLS (KKKRD, amino acids 125–129). (B) Western blot analysis of cell-free extracts
prepared from HeLa cells transfected with no plasmid (lane 1), pEGFP (lane 2), p3C-EGFP (lane 3), p3D-EGFP (lane 4), p3CD-EGFP (lane 5), and pm3CD-
EGFP (lane 6). The Q–G pair at the 3C–3D junction in m3CD-EGFP is mutated to an ala–ala pair to prevent processing into 3C and 3D.
Fig. 2. EGFP fluorescence profiles of cells transfected with various EGFP-fusion constructs. The cells were transfected with pEGFP (A, inset), p3C-EGFP (A,
B, G, and H), p3D-EGFP (C, D, I, and J), and p3CD-EGFP (E, F, K, and L). Transfected cells were either mock-infected (MOCK) or PV-infected (INF) for 4 h
and EGFP fluorescence visualized using a fluorescence microscope (panels A–F). The cells shown in panels G–L were stained with PI to visualize nuclei.
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Fig. 3. EGFP fluorescence profiles of cells transfected with EGFP-fusion constructs. The cells transfected with pm3CD-EGFP (A, B, E, and F) and pPK-EGFP
(C, D, G, and H) were either mock-infected (MOCK) or PV-infected (INF) and EGFP fluorescence visualized by fluorescence microscopy (panels A–D). The
cells shown in panels E–H were stained with PI to visualize nuclei.
Fig. 4. Expression of 3D-EGFP and 3CD-EGFP NLS mutants. Cell-free
extracts recovered from cells transfected with p3DAAARD-EGFP (lane 1),
p3DKKAAA-EGFP (lane 2), p3CDAAARD-EGFP (lane 3), and p3CDKKAAA-
EGFP (lane 4) were analyzed by Western blot using anti-EGFP.
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determine nuclear entry of 3CD for all experiments de-
scribed below. When HeLa cells were transfected with
pEGFP, EGFP expression was detected throughout the cell
(Fig. 2A, inset). A similar pattern of fluorescence was
observed in cells transfected with p3C-EGFP (Fig. 2A).
This type of overall distribution of 3C-EGFP could be due
to generation of relatively high quantities of free GFP in
cells transfected with p3C-EGFP, which was evident from
the immunoblot analysis of proteins from p3C-EGFP trans-
fected cells (Fig. 1B, lane 3). Infection of p3C-EGFP
transfected cells with PV did not significantly change the
EGFP fluorescence profile except that the cells became
round in appearance (Fig. 2B). Mock-infected HeLa cells
expressing 3D-EGFP showed distinct cytoplasmic/ perinu-
clear localization (Fig. 2C). In contrast to 3C-EGFP, there
was no significant 3D-EGFP fluorescence in the nucleus of
mock-infected cells. These results are consistent with a
previous report in which PV proteins were expressed
following infection of mosquito cells with a recombinant
baculovirus (Neufeld et al., 1991). Infection with PVof cells
expressing 3D-EGFP resulted in significant increase in
fluorescence within the nucleus compared with the mock-
infected control (Fig. 2D, also see Fig. 5A). Similar results
were observed in 3CD-EGFP-expressing cells; 3CD-EGFP
was primarily localized in the cytoplasm in mock-infected
cells and infection with PV led to translocation of significant
amount of 3CD into the nucleus (Figs. 2E and F). Nuclear
staining of these cells by propidium iodide (PI) showed that
the nuclei were intact after 4 h of infection (Figs. 2G–L). To
rule out the possibility that 3CD-EGFP nuclear relocaliza-tion in infected cells could be due to generation of 3D-EGFP
by proteolysis (or auto-proteolysis), a mutant 3CD-EGFP
was used to transfect HeLa cells. In this mutant (m3CD-
EGFP), the scissile gln–gly bond at the 3C–3D junction
was mutated to an ala–ala pair to prevent proteolysis. In
vitro protease cleavage assays showed that m3CD-EGFP
was completely resistant to cleavage by exogenously added
3C protease (data not shown). As can be seen in Figs. 3A
and B, the m3CD-EGFP protein behaved in a similar
Fig. 5. EGFP fluorescence profile of cells transfected with p3D-EGFP and p3CD-EGFP NLS mutants. HeLa cells transfected with wt p3DKKKRD-EGFP (A), wt
p3CDKKKRD-EGFP (F), and NLS mutants p3DAAARD-EGFP (B and C), p3DKKAAA-EGFP (D and E), and p3CDKKAAA-EGFP (G and H) were analyzed by
fluorescence microscopy. Mutant 3D-EGFP and 3CD-EGFP transfected cells were either mock-infected (MOCK) or infected with PV (INF). Only infected
cells are shown for wt 3D-EGFP and 3CD-EGFP transfected cells.
Fig. 6. EGFP fluorescence profile of cells transfected with pm3CD-EGFP
NLS mutants. The pm3CD-EGFP fusion plasmid with the wt NLS (A),
and pm3CD-EGFP containing the mutated NLS sequence (KKKRD to
KKAAA) (B, C) were transfected into HeLa cells. Transfected cells were
either mock-infected (B) or PV-infected (A and C) for 4 h.
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and F). Majority of the m3CD-EGFP was present in the
cytoplasm of uninfected cells and PV infection resulted in
nuclear entry of significant amount of this protein. As a
control, HeLa cells were transfected with a commercially
available soluble protein kinase (PK), which lacks a NLS.
Transfection of cells with pPK-EGFP resulted in cytoplas-
mic expression of this protein as expected (Fig. 3C).
Infection of cells expressing pPK EGFP with PV for 4
h did not result in significant nuclear fluorescence of this
soluble protein compared with the mock-infected cells (Fig.
3D). Panels E–H (Fig. 3) show staining of nuclei by PI. The
results presented in Figs. 2 and 3 suggest that a significant
portion of total 3CD and 3D enter the nucleus in cells
infected with PV.
NLS mutation interferes with nuclear entry of 3D and 3CD
in PV-infected cells
To determine whether the NLS present within the 3D
sequence plays a role in nuclear entry of 3D and 3CD, the
wt NLS sequence (KKKRD) was mutated to either
AAARD or KKAAA by triple alanine substitution. These
mutations, when introduced into the infectious PV cDNA
clone, were found to be lethal (Diamond and Kirkegaard,
R. Sharma et al. / Virology 320 (2004) 195–2052001994). Both mutants were expressed in HeLa cells as
EGFP-fusion proteins. Western analyses revealed that both
the 3D(AAARD)-EGFP and 3D(KKAAA)-EGFP polypep-
tides were produced in transfected cells and the level of
expression was similar to that of the wt 3D-EGFP (Fig. 4,
lanes 1 and 2), and data not shown). Similarly, the recom-
binant 3CD-EGFP harboring the KKAAA NLS mutation
was expressed in significant amounts and was stable under
the conditions used for expression (Fig. 4, lane 4). Surpris-
ingly, despite repeated attempts, we were unable to express
the full-length, recombinant 3CD-EGFP harboring the
AAARD mutation in reasonable quantities. Western analy-
sis revealed that the majority of expressed protein was
degraded to a number of lower molecular weight polypep-
tides that included significant amount of EGFP and at least
two other products having molecular masses of approxi-
mately 55 and 43 kDa (indicated by arrowheads, Fig. 4,
lane 3). The 55-kDa band detected here could be the same
polypeptide as seen previously in Fig. 1B (lanes 5 and 6).
We do not know the precise reasons for the instability of
3CD(AAARD)-EGFP. It is possible that the mutationFig. 7. Detection of 3D and 3CD in nuclear and cytoplasmic fractions recovered fro
infected with PV (B) at an moi of 25 for 0 (lanes 1 and 2), 1 (lanes 3 and 4), 2 (l
cytoplasmic (C) fractions prepared from these cells were examined by Western blo
(WCE) from 4 h infected cells was examined by Western analysis using anti-3D an
lamin for cytoplasmic and nuclear fractions, respectively, as loading controls. (D
infected for 0 (lanes 2 and 3), 3 (lanes 4 and 5), and 4 (lanes 6 and 7) h of infectio
analysis of a whole cell extract recovered from 4 h infected cells. The panel on the(KKKRD to AAARD) introduced into the protein has
somehow made this polypeptide unstable. It should be
noted, however, that that the same mutation had no signif-
icant effect on the stability of 3D-EGFP (Fig. 4, lane 1).
We, therefore, were unable to use the 3CD(AAARD)-EGFP
plasmid in the following experiment to delineate the effects
of the NLS mutations on nuclear-cytoplasmic distribution of
3CD. The nuclear-cytoplasmic distribution of the mutant
polypeptides 3D(AAARD)-EGFP, 3D(KKAAA)-EGFP, and
3CD(KKAAA)-EGFP was examined in PV- or mock-
infected cells by fluorescence microscopy. In this particular
experiment, the localization of wt 3D-EGFP in PV-infected
cells was distinctly nuclear, although some fluorescence
was detected throughout the cell cytoplasm (Fig. 5A).
Infected cells expressing wt 3CD-EGFP showed both cy-
toplasmic and nuclear fluorescence (Fig. 5F). Although not
shown here, expression patterns of both wt 3D-EGFP and
3CD-EGFP in mock-infected cells were almost identical to
that seen previously (Figs. 2C and E). In the absence of PV
infection, both the 3CD-EGFP and 3D-EGFP mutants were
predominantly localized in the cell cytoplasm (perinuclear,m PV-infected cells. HeLa cells (3  106) were mock-infected for 4 h (A) or
anes 5 and 6), 3 (lanes 7 and 8), and 4 (lanes 9 and 10) h. Nuclear (N) and
t analysis using a polyclonal antibody to 3D. In lane 11, a whole cell extract
tibody. (C) The upper and lower panels show Western analyses of actin and
) Cytoplasmic (C) and nucleoplasmic (N) fractions recovered from cells
n were used for Western analysis using 3D antibody. Lane 1 shows Western
right shows an overexposed blot for lanes 4–7 from the same experiment.
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F), infection with PV did not result in significant redistri-
bution of the mutant proteins into the nucleus (Figs. 5C, E
and H). These results suggest that triple alanine substitution
of the NLS prevent nuclear entry of 3D and 3CD in PV-
infected HeLa cells. We also examined the localization
pattern of m3CD-EGFP with the KKAAA NLS mutation.
The cells transfected with pm3CD-EGFP containing the wt
NLS (KKKRD) sequence showed GFP fluorescence both in
the cytoplasm and nucleus (Fig. 6A). However, the majority
of m3CD(KKAAA)-EGFP was found to localize to the
cytoplasm irrespective of whether the cells were mock-
infected or infected with PV (Figs. 6B and C). These results
suggest that both the NLS and PV infection are required for
entry of 3D and 3CD into the nucleus.
Detection of 3CD in nuclear fractions from PV-infected
HeLa cells
To confirm results of transient transfection experiments
using the pEGFP-fusion plasmids, we examined distribution
of viral 3CD/3D polypeptides in nuclear and cytoplasmic
fractions of HeLa cells infected with PV. HeLa monolayer
cells were infected with PV at a multiplicity of infection
(moi) of 25 and cells were harvested at 0, 1, 2, 3, and 4
h postinfection. Cell-free lysates were prepared following
cell lysis and removal of membrane and cell debris by
centrifugation. Nuclei were separated from the cytoplasmic
fraction by centrifugation followed by repeated washing of
the nuclei with buffer containing non-ionic detergent NP-40.
The washing step was repeated until 3CD could no longer
be detected in the wash. Nuclear extracts were then prepared
and 20 Ag of cytoplasmic and nuclear extracts were exam-
ined by Western blot analysis using a polyclonal antibody to
3D. As can be seen in Fig. 7B, no viral protein could be
detected in cytoplasmic or nuclear fractions harvested at 0
and 1 h of infection (lanes 1–4). The two background
polypeptides migrating at approximately 44 and 69 kDa in
the cytoplasmic fraction and one polypeptide (f44 kDa) in
the nuclear fraction (indicated by arrowheads, lanes 1–4,
Fig. 7B) were also detected in nuclear and cytoplasmic
fractions prepared from mock-infected cells (Fig. 7A). A 72-
kDa polypeptide that comigrates with 3CD was detected as
early as 2 h postinfection in both cytoplasmic and nuclear
fractions (Fig. 7B, lanes 5 and 6). At 3 h postinfection,
considerable amount of 3CD was detected in the nuclear
fraction (lane 8). In contrast to 3CD, very little 3D poly-
merase was detected in the nuclear fraction at 3 h postinfec-
tion (lane 8). Considerable amounts of both 3CD and 3D
polypeptides were detected in the nuclear fraction at 4
h postinfection (lane 10). We also detected another virus-
encoded protein in the nuclear fraction at 3 h postinfection,
which migrated slower than 3CD (lanes 8). The estimated
molecular weight (f86 kDa) and migration pattern of this
polypeptide was consistent with that of the viral precursor
P3. Fig. 7C shows Western analyses of actin and lamin fromthe cytoplasmic and nuclear fractions, respectively from
infected cells as loading controls. We also examined the
possibility that a portion of the 3CD in the nuclear fraction
could be associated with the nuclear membrane rather than
being nucleoplasmic. Therefore, the nucleoplasmic fraction,
after removal of nuclear membranes, was examined by
Western blot analysis. As can be seen in Fig. 7D, significant
amount of 3CD was still present in the nucleoplasmic
fraction at 3 and 4 h postinfection (lanes 5 and 7). Overex-
posure of the same immunoblot showed considerable
amounts of both 3CD and 3D at 4 h as well as a small
amount of the precursor predicted to be P3 (indicated by an
arrow). These results suggest that 3CD and possibly some
other 3D precursors are capable of translocating into the
nucleus in PV-infected cells.Discussion
We have shown that the PV-encoded protease precursor
3CD is capable of translocating into the nucleus in PV-
infected cells. Both the transiently expressed 3CD-EGFP-
fusion protein and the native 3CD polypeptide synthesized
in PV-infected cells were found to translocate into the
nucleus within 2–4 h of infection. This ability to enter
nucleus resides within the 3D portion of 3CD, which
contains a single basic type NLS, KKKRD, between amino
acids 125 and 129. Mutation of the NLS sequence prevents
entry of 3CD/3D into the nucleus. The results presented
here also suggest that the presence of NLS alone is not
sufficient for nuclear entry of 3D/3CD; additional alter-
ations in the nuclear membrane brought about by PV
infection is also required for successful nuclear transloca-
tion of 3CD/3D.
Cells infected with PV undergo numerous changes that
include shut-off of host cell translation and transcription
(Dasgupta et al., 2003; Etchison et al., 1982; Gradi et al.,
1998), inhibition of host protein secretion (Doedens and
Kirkegaard, 1995), both induction and inhibition of apopto-
sis (Agol et al., 2000; Tolskaya et al., 1995), and the
conversion of ER membranes to viral replication complexes
(Bienz et al., 1983; Suhy et al., 2000). Whether one or more
of these processes play any role in 3CD/3D nuclear trans-
location is not known. However, recent studies have shown
that PV infection can cause inhibition of nuclear-cytoplas-
mic trafficking leading to accumulation of nuclear proteins
in the cytoplasm (Belov et al., 2000; Gustin and Sarnow,
2001, 2002). Nuclear proteins such as the La autoantigen,
Sam 68, and nucleolin accumulate in the cytoplasm of
infected cells and interact with either viral RNA or virus-
encoded proteins (McBride et al., 1996; Meerovitch et al.,
1993; Waggoner and Sarnow, 1998). The cytoplasmic
retention of La in PV-infected cells may, at least in part,
be due to truncation of La by the 3C protease resulting in the
loss of NLS (Shiroki et al., 1999). However, many proteins
that relocate to the cytoplasm retain their NLS (Belov et al.,
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latter class of proteins in the cytoplasm could result from
alteration of the nuclear pore complex as well as inhibition
of active nuclear import. The TATA-binding protein (TBP),
which is the major target for PV protease 3C, was found not
to relocalize to the cytpoplasm of infected cells (Gustin and
Sarnow, 2001). The inability of TBP to be translocated to
the cytoplasm of infected cells necessitates entry of 3C and/
or 3CD or some other 3C-containing precursor into the
nucleus and subsequent cleavage of TBP leading to shut-off
of host cell transcription. It is interesting to note that despite
accumulation of cellular proteins in the infected cell cyto-
plasm, virus-encoded proteins (3CD/3D) are capable of
moving in the opposite direction in a NLS-dependent
fashion. Therefore, nuclear import pathways must be oper-
ational in spite of general inhibition of nuclear import in
infected cells. Indeed, a previous study found that not all
nuclear transport/import systems are affected in PV-infected
cells (Gustin et al., 2001).
The results presented in this paper do not rule out the
possibility that 3C protease itself could enter the nucleus,
leading to cleavage of TBP or other transcription factors. In
fact, overexpression of 3C alone in mammalian cells leads
to shut-off of pol III transcription (Clark et al., 1991). At
sufficiently high concentrations, such as overexpression or
late times postinfection, 3C could conceivably diffuse into
the nucleus and inhibit transcription. However, this may not
be the case early during infection when the concentration of
3C is not high enough to successfully defuse into the
nucleus. This is particularly relevant for RNA pol I tran-
scription shut-off, which occurs very early (1.5–2 h)
postinfection accompanied by multiple cleavage of the
TBP-associated factor (TAF) 110, a pol I factor, at gln–
gly sites (Dasgupta et al., 2003; Banerjee and Dasgupta,
unpublished results). We could only detect 3CD but no free
3C in the infected cells between 1.5 and 2 h postinfection.
Thus, it is conceivable that 3CD might translocate into the
nucleus as early as 1.5–2 h postinfection to shut-off RNA
pol I catalyzed synthesis of rRNA. Although purified 3CD
does not directly cleave purified TBP in vitro (Dasgupta et
al., 2003), we cannot rule out the possibility that it could
cleave transcription factors in vivo. Efficient processing of
the viral capsid precursor P1 by 3CD appears to be
dependent on a cellular polypeptide (Blair et al., 1993). It
is, therefore, possible that 3CD in association with cellular
proteins could cleave TBP or other transcription factors in
infected cells.
The lack of distinct localization of 3C-EGFP in p3C-
EGFP transfected cells did not allow us to make any valid
conclusions regarding nuclear entry of 3C. This was due, at
least in part, to generation of relatively high amounts of free
EGFP in these cells, which made it difficult to determine
intracellular localization of 3C-EGFP. The precise reason for
the generation of high amounts of EGFP in p3C-EGFP
transfected cells is not known. The cloning strategy used to
make the 3C-EGFP-fusion polypeptide did not generatepotential 3C cleavage sites at or near the junction of 3C
and EGFP. We were also surprised with the finding that
almost no full-length protein was found in cells transfected
with the p3CD-EGFP containing the AAARD NLS muta-
tion (Fig. 4, lane 3). The same mutation in 3D-EGFP,
however, did not result in the lack of synthesis/breakdown
of the full-length protein (Fig. 4, lane 1). It is possible that
the NLS mutation (KKKRD to AAARD) introduced into
the protein might have destabilized the polypeptide leading
to its cleavage and/or degradation. We also do not know
whether viral (3C) or cellular proteases contribute to the
instability of this polypeptide in vivo. Further studies will be
required to answer these questions.
The results presented here suggest that cleavage between
3C and 3D is not necessary for nuclear entry of 3CD-EGFP.
First, a significant fraction of m3CD-EGFP in which the Q–
G bond between 3C and 3D is not cleaved in vitro (data not
shown), translocates into the nucleus following PV infection
(Figs. 3A and B). Secondly and more importantly, when the
KKAAA NLS mutation is introduced into m3CD-EGFP, the
protein is found almost exclusively in the cytoplasm of PV-
infected cells (Fig. 6C). This is in contrast to the m3CD-
EGFP with the wt NLS, a significant amount of which
migrates to the nucleus following PV infection (Figs. 3A
and B). Thus, both the wt 3CD and m3CD behave similarly
with respect to cellular localization in PV-infected HeLa cells.
Why does 3D-EGFP (or 3CD-EGFP) not enter nucleus in
transfected cells (in the absence of virus infection) despite
the presence of a fairly well conserved NLS sequence? It is
possible that the NLS sequence may not be exposed in the
absence of other viral proteins. Virus infection may be
required for interaction of 3CD/3D with one or more viral
or cellular proteins before entry into the nucleus. It is
interesting to note that bipartite nuclear signal sequences,
called NLS I and II, were required for efficient entry of
potyviral NIa, the VPg-protease precursor, into the nucleus
of infected cells. When used individually, NLS I and II could
facilitate very low level of translocation of the precursor
protein (Carrington et al., 1991). The potyviral NIb, the
RNA-dependent RNA polymerase, also contains an NLS
and mutations in this sequence interfere with nuclear local-
ization of NIb (Li and Carrington, 1995; Li et al., 1997;
Schaad et al., 1996).
The results of transient transfections using pEGFP-
fusion plasmids are consistent with the observation that
both virus-encoded 3CD and 3D are detected in the
nuclear fraction in PV-infected HeLa cells (Fig. 7). In
fact, considerable amount of 3CD is detected in the
nuclear fraction by 3 h postinfection. Also, significant
amounts of 3CD and 3D could be detected in the
nucleoplasm of infected cells (Fig. 7D). A 3D-containing
viral precursor protein with an approximate molecular
mass of 86 kDa was also detected in the nuclear fraction
(Figs. 7B and D). The estimated molecular weight and
migration pattern of this polypeptide are consistent with
that of the precursor P3. Although this observation raises
R. Sharma et al. / Virology 320 (2004) 195–205 203the possibility that 3CD and 3D may be generated in the
nucleus by processing of P3, the transient transfection
data clearly show that both 3CD and 3D are capable of
entering the nucleus on their own.
It is interesting to note that the putative NLS (KKKRD) in
the 3D coding region is partially contained within a se-
quence, KKRDI, which is common among all known picor-
naviral RNA polymerases. This suggests that this sequence
might have an important function in the virus life cycle. One
distinct possibility why it is so conserved could be that this
sequence might act as a true NLS and that nuclear translo-
cation of certain viral proteins could be essential for efficient
replication and spread of the virus in the infected host.
Further characterization of the role of the putative NLS in
nuclear transport of PV non-structural proteins will add to
our understanding of how and why cytoplasmic RNAviruses
interact with the nuclei. In this regard, it can be said that a
portion of life cycle of a cytoplasmic RNAvirus does include
interaction with the host cell nucleus.Materials and methods
Cells and viruses
HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (Gibco BRL, Gaithersburg, MD) supplemented
with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin G,
and 100 Ag/ml streptomycin. DNA transfections were per-
formed using the lipofectamine plus reagent (Gibco/BRL)
following the manufacturer’s recommendations. HeLa cells
were seeded in six-well plates and allowed to reach 70%
confluency. Transfection was performed by addition of 1.5–
2.0 Ag of DNA, 5 Al lipofectamine and 4 Al plus reagent to
HeLa cells for 3 h. Cells were then fed with regular medium
and allowed to grow for 24 h. Cells were infected with PV
(type 1, Mahoney strain) at an moi of 25 as previously
described (Clark et al., 1991).
Subcellular fractionation
HeLa monolayer (3  106) cells were infected or mock-
infected with PV (type 1, Mahoney strain) at an moi of 25
for 0, 1, 2, 3, and 4 h. The cells were collected at
appropriate times postinfection and fractionated into nucle-
ar and cytoplasmic fractions as previously described (Hu et
al., 1998). Briefly, the cells were washed 3 times with PBS,
scraped into a tube, and peletted by centrifugation at 400 
g for 1–2 min at 4 jC. The cells were resuspended in 500–
600 Al buffer C (10 mM Tris, pH 7.8, 5 mM MgCl2, 10
mM KCl, 0.3 mM EGTA, 0.5 mM DTT, 0.3 M sucrose, 10
mM h-glycerol phosphate, and 2 mM ZnCl2). After incu-
bating for 15 min on ice, NP-40 was added to a final
concentration of 0.5%. The cells were then vortexed, and
nuclei were isolated after centrifugation at 7200  g for
20–30 s at 4 jC. The nuclei were washed 5 times withbuffer C. In some experiments, the nuclear fraction was
resuspended in buffer D (20 mM Tris, pH 7.8, 5 mM
MgCl2, 320 mM KCl, 0.2 mM EGTA, 0.5 mM DTT, and 2
mM ZnCl2). After sonication for 10–20 s, nuclear soluble
fraction (nucleoplasm) was separated from nuclear mem-
brane fraction (pellets) by centrifugation at 13,500  g for
15 min at 4 jC.
Plasmids and cloning
The cloning strategy for EGFP-fusion proteins is
depicted in Fig. 1A. Briefly, the DNA sequences encoding
3C, 3D, and 3CD were fused with GFP sequence at the N
terminus using pEGFP-N1 N-terminal protein fusion vector
(Clontech). The multiple cloning site (MCS) in the pEGFP-
N1 vector is between the immediate early promoter of CMV
and the EGFP coding sequences. Genes cloned into the
MCS will be expressed as fusions to the N terminus of
EGFP if they are in the same reading frame as EGFP and
there are no intervening stop codons. SV-40 polyadenylation
signals downstream of the EGFP gene direct proper pro-
cessing of the 3V end of the EGFP mRNA. The DNA
sequences encoding 3C, 3D, 3CD, and m3CD were PCR
amplified using specific primers containing the Kpn1 and
BamH1 restriction sites. Following amplification and gel
purification, the viral protein coding sequences were cloned
between the Kpn1 and BamH1 sites of the pEGFP-N1 MCS.
All constructs were verified by DNA sequencing as well as
immunoblotting with antibodies directed against GFP
(Clontech). The following primers were used for PCR
amplification:
3C (forward): 5VGACGGTACCTATGGGACCAGG-
GTTCGATTACGCA 3V
3C (reverse): 5VGGTGGATCCATTTGACTCTGAGT-
GAAGTATGA 3V
3D (forward): 5VGACGGTACCTATGGGTGAAATC-
CAGTGGATGAGA 3V
3D (reverse): 5VGGTGGATCCATAAATGAGTCAAGC-
CAACGGCG 3V.
For amplification of 3CD, the 3C forward and 3D reverse
primers were used.
The following primers were used to mutate the KKKRD
NLS sequence to AAARD:
(forward primer): 5VTATGTAGCAATGGGAGC-
CGCGGCGAGAGACATCTTFAAC 3V
(reverse primer): 5VGTTCAAGATGTCTCTCGC-
CGCGGCTCCCATTGCTACATA 3V.
The following primers were used to alter KKKRD NLS
sequence to KKAAA:
(forward primer): 5VGCAATGGGAAAGAAGGCGGC-
CGCGATCTTGAACAAACAA 3V,
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GCCTTCTTTCCCATTGC 3V.
The pm3CD-EGFP construct is same as p3CD-EGFP
except that the gln–gly pair at the 3C–3D junction has been
mutated to an ala–ala pair.
The following forward and reverse primers were used to
mutate the gln–gly pair at the 3C–3D junction:
5VGATCATACTTCACTCAGAGTGCGGCTGAAAT-
CCAGTGGATG 3V, and
5VCATCCACTGGATTTCAGCCGCACTCTGAGT-
GAAGTATGATC 3V.
Immunoblotting
HeLa cell-free lysates were prepared by washing cells
once with PBS, followed by resuspending them in 1
passive lysis buffer (Promega). Cells were lysed by repeated
freeze–thawing in dry ice–alcohol bath followed by incu-
bation at 30 jC. The lysate protein concentration was then
determined by the Bradford method (Bio-Rad) and proteins
separated by 4–15% gradient SDS-polyacrylamide gel
electrophoresis. The proteins were then transferred to nitro-
cellulose membrane, and the membrane probed with a rabbit
polyclonal antibody specific to GFP (Clontech and Molec-
ular Probe). Immunoreactive proteins were detected with
goat anti-rabbit antibody conjugated to horseradish peroxi-
dase (Roche) using the supersignal chemiluminescence kit
(Pierce). For detection of PV proteins in infected cells, 20–
40 Ag of cell-free extracts were used in Western analysis
using a rabbit polyclonal antibody against bacterially
expressed 3D polypeptide. The antibody to 3D was gener-
ously supplied by Dr. Ellie Ehrenfeld, NIH.
Microscopy
HeLa cells were washed once with PBS 24 h after
transfection, fixed for 20 min in chilled absolute methanol
at 20 jC, and again washed with PBS-CM-BSA (PBS
containing 0.9 mM CaCl2, 0.83 mM MgCl2, and 3 mg/ml
BSA) 2 times. Cells were then incubated with 20 Ag/ml
RNase for 30 min, washed 3 times with PBS-CM-BSA, and
incubated with PI for 15 min at 4 jC. The cells were then
washed again with PBS-CM-BSA 2 times and mounted on
slides (Vectashield). Cells were visualized using a Nikkon
Diaphot 200 inverted fluorescence microscope attached with
a CCD camera.Acknowledgments
This work was supported by the NIH grant AI 27451 to
A.D. The authors thank the members of the Dasgupta
laboratory for their help during the course of this work. Weare grateful to Dr. Ellie Ehrenfeld for the generous supply of
antibody to poliovirus 3D used in this study.References
Agol, V.I., Belov, G.A., Bienz, K., Egger, D., Kolesnikova, M.S., Roma-
nova, L.I., Sladkova, L.V., Tolskaya, E.A., 2000. Competing death
programs in poliovirus-infected cells: commitment switch in the middle
of the infectious cycle. J. Virol. 74, 5534–5541.
Belov, G.A., Evstafieva, A.G., Rubtsov, Y.P., Mikitas, O.V., Vartapetian,
A.B., Agol, V.I., 2000. Early alteration of nucleocytoplasmic traffic
induced by some RNA viruses. Virology 275, 244–248.
Bienz, K., Egger, D., Rasser, Y., Bossart, W., 1982. Accumulation of polio-
virus proteins in the host cell nucleus. Intervirology 18, 189–196.
Bienz, K., Egger, D., Rasser, Y., Bossart, W., 1983. Intracellular distribu-
tion of poliovirus proteins and the induction of virus-specific cytoplas-
mic structures. Virology 131, 39–48.
Blair, W.S., Li, X., Semler, B.L., 1993. A cellular cofactor facilitates
efficient 3CD cleavage of the poliovirus P1 precursor. J. Virol. 67,
2336–2343.
Carrington, J.C., Freed, D.D., Leinicke, A.J., 1991. Bipartite signal se-
quence mediates nuclear translocation of the plant potyviral NIa protein.
Plant Cell 3 (9), 953–962.
Clark, M.E., Dasgupta, A., 1990. A transcriptionally active form of
TFIIIC is modified in poliovirus-infected cells. Mol. Cell. Biol. 10,
5106–5113.
Clark, M.E., Hammerle, T., Wimmer, E., Dasgupta, A., 1991. Poliovirus
proteinase 3C converts an active form of transcription factor IIIC to an
inactive form: a mechanism for inhibition of host cell pol III transcrip-
tion by poliovirus. EMBO J. 10, 2941–2947.
Clark, M.E., Lieberman, M., Berk, A.J., Dasgupta, A., 1993. Direct clea-
vage of human TATA-binding protein by poliovirus protease 3C in vivo
and in vitro. Mol. Cell. Biol. 13, 1232–1237.
Dasgupta, A., et al., 2003. In: Semler, B.L., Wimmer, E. (Eds.), Molecular
Biology of Picornaviruses. ASM press, Washington D.C., pp. 321–335.
Diamond, S., Kirkegaard, K., 1994. Clustured charged-to-alanine muta-
genesis of poliovirus RNA-dependent RNA polymerase yields multip-
lets mutants defective in RNA synthesis. J. Virol. 68, 863–876.
Dingwall, C., Laskey, R.A., 1991. Nuclear targeting sequences a consen-
sus? Trends Biochem. Sci. 16, 478–491.
Doedens, J.R., Kirkegaard, K., 1995. Inhibition of cellular protein secretion
by poliovirus proteins 2B and 3A. EMBO J. 14, 894–907.
Etchison, D., Mulburn, S.C., Edery, I., Sonenberg, N., Hershey, J.W.B.,
1982. Inhibition of Hela cell protein synthesis following poliovirus
infection correlates with the proteolysis of a 220,000-dalton polypeptide
associated with eukaryotic initiation factor 3 and a cap binding protein
complex. J. Biol. Chem. 257, 14806–14810.
Falk, M.M., et al., 1990. Foot-and-mouth disease virus protease 3C indu-
ces specific proteolytic cleavage of host cell histone H3. J. Virol. 64,
748–756.
Fernandez, T.C., 1982. The presence of viral induced proteins in nuclei
from poliovirus-infected HeLa cells. Virology 116, 629–634.
Gradi, A., Svitkin, Y.V., Imataka, H., Sonenberg, N., 1998. Proteolysis of
human translation initiation factor eIF4GII, but not eIF4GI, coincides
with the shut-off of host protein synthesis after poliovirus infection.
Proc. Natl. Acad. Sci. U.S.A. 95, 11089–11094.
Gustin, K.E., Sarnow, P., 2001. Effects of poliovirus infection on nucleo-
cytoplasmic trafficking and nuclear pore complex composition. EMBO
J. 20, 240–249.
Gustin, K.E., Sarnow, P., 2002. Inhibition of nuclear import and alter-
ation of nuclear pore complex formation by rhinovirus. J. Virol. 76,
8787–8796.
Hansen, J., Long, A., Schultz, S., 1997. Structure of the RNA-dependent
RNA polymerase of poliovirus. Structure 5, 1109–1122.
R. Sharma et al. / Virology 320 (2004) 195–205 205Harris, K.S., Reddigari, S.R., Nicklin, M.J., Hammerle, T., Wimmer, E.,
1992. Purification and characterization of poliovirus polypeptide 3CD,
a proteinase and a precursor for RNA polymerase. J. Virol. 66,
7481–7489.
Hu, Y., Fisette, P.L., Denlinger, L.C., Guadarrama, A.G., Sommer, J.A.,
Proctor, R.A., Bertics, P.J., 1998. Purinergic receptor modulation of
lipopolysaccharide signaling and inducible nitric oxide synthase expres-
sion in RAW 264.7 macrophages. J. Biol. Chem. 273, 27170–27175.
Kaariainen, L., Ranki, M., 1984. Inhibition of cell functions by RNA virus
infections. Annu. Rev. Microbiol. 38, 91–109.
Krausslich, H., Wimmer, E., 1988. Viral proteinases. Annu. Rev. Biochem.
57, 701–754.
Lawson, M.A., Semler, B.A., 1990. Picornavirus protein processing—En-
zymes, substrates and genetic regulation. Curr. Top. Microbiol. Immu-
nol. 161, 49–87.
Leong, L.E.-C., Cornell, C.T., Semler, B.A., 2003. In: Semler, B.L.,
Wimmer, E. (Eds.), Molecular Biology of Picornaviruses. ASM press,
Washington D.C., pp. 187–197.
Li, X.H., Carrington, J.C., 1995. Complementation of tobacco etch poty-
virus mutants by active RNA polymerase expressed in transgenic cells.
Proc. Natl. Acad. Sci. U.S.A. 92, 457–461.
Li, X.H., Valdez, P., Olvera, R.E., Carrington, J.C., 1997. Functions of the
tobacco etch virus RNA polymerase (NIb): subcellular transport and
protein –protein interaction with VPg/proteinase (Nia). J. Virol. 71,
1598–1607.
McBride, A.E., Schlegel, A., Kirkegaard, K., 1996. Human protein Sam68
relocalization and interaction with poliovirus RNA polymerase in in-
fected cells. Proc. Natl. Acad. Sci. U.S.A. 93, 2296–2301.
Meerovitch, K., Svitkin, Y.V., Lee, H.S., Lezbkowicz, F., Kenan, D.J.,
Chan, E.K., Agol, V.I., Keene, J.D., Sonenberg, N., 1993. La autoan-
tigen enhances and corrects aberrant translation of poliovirus RNA in
reticulocyte lysate. J. Virol. 67, 3798–3807.
Neufeld, K.L., Richards, O.C., Ehrenfeld, E., 1991. Expression and char-
acterization of poliovirus proteins 3BVPg, 3Cpro, and 3Dpol in re-
combinant baculovirus infected Spodoptera frugiperda cells. Virus
Res. 19, 173–188.
Parsley, T.B., Cornell, C.T., Semler, B.L., 1999. Modulation of the RNA
binding and protein processing activities of poliovirus polypeptide
3CD by the viral RNA polymerase domain. J. Biol. Chem. 274,
12867–12876.Rubinstein, S.J., Dasgupta, A., 1989. Inhibition of rRNA synthesis by
poliovirus: specific inactivation of transcription factors. J. Virol. 63.
Rubinstein, S.J., Hammerle, T., Wimmer, E., Dasgupta, A., 1992. Infection
of HeLa cells with poliovirus results in modification of a complex that
binds to the rRNA promoter. J. Virol. 66, 3062–3068.
Schaad, M.C., Haldeman-Cahill, R., Cronin, S., Carrington, J.C., 1996.
J. Virol. 70, 7039–7048.
Shiroki, K., Isoyama, T., Kuge, S., Ishii, T., Ohmi, S., Hata, S., Suzuki, K.,
Takasaki, Y., Nomoto, A., 1999. Intracellular redistribution of truncated
La protein produced by poliovirus 3Cpro-mediated cleavage. J. Virol.
73, 2193–2200.
Suhy, D.A., Giddings Jr., T.H., Kirkegaard, K., 2000. Remodeling of the
endoplasmic reticulum by poliovirus infection and by individual viral
proteins: an autophagy-like origin for virus-induced vesicles. J. Virol.
74, 8953–8965.
Tolskaya, E.A., Romanova, L.I., Kolesnikova, M.S., Ivannikova, T.A.,
Smirnova, E.A., Raikhlin, N.T., Agol, V.I., 1995. Apoptosis-indu-
cing and apoptosis-preventing functions of poliovirus. J. Virol. 69,
1181–1189.
Waggoner, S., Sarnow, P., 1998. Viral ribonucleoprotein complex formation
and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus in-
fected cells. J. Virol. 72, 6699–6709.
Weidman, K., Yalamanchili, P., Ng, B., Tsai, W., Dasgupta, A., 2001.
Poliovirus 3C-mediated degradation of transcriptional activator p53 re-
quires a cellular activity. Virology 291, 260–271.
Wimmer, E., Hellen, C.U.T., Cao, X., 1993. Genetics of poliovirus. Annu.
Rev. Genet. 27, 353–436.
Yalamanchili, P., Harris, K., Wimmer, E., Dasgupta, A., 1996. Inhibition of
basal transcription by poliovirus: a virus encoded protease (3Cpro) in-
hibits formation of TBP-TATA box complex in vitro. J. Virol. 70,
2922–2929.
Yalamanchili, P., Datta, U., Dasgupta, A., 1997a. Inhibition of host cell
transcription by poliovirus: cleavage of transcription factor CREB by
poliovirus-encoded protease 3Cpro. J. Virol. 71, 1220–1226.
Yalamanchili, P., Weidman, K., Dasgupta, A., 1997b. Cleavage of tran-
scriptional activator Oct-1 by poliovirus-encoded protease 3Cpro. Virol-
ogy 239, 176–185.
Ypma-Wong, M.F., Dewalt, P.G., Johnson, V.H., Lamb, J.G., Semler, B.L.,
1988. Protein 3CD is the major poliovirus proteinase responsible for
cleavage of the P1 capsid precursor. Virology 166, 265–270.
